To sustain homeostasis and other critical processes, the brain is a very sensitive and delicate neuronal organ system that requires a steady supply of fuels, gases, and nutrients. The blood-brain barrier (BBB) has proven to be a significant obstacle to drug delivery to the brain. The BBB in a healthy brain serves as a diffusion barrier that prevents most compounds from passing from the bloodstream to the brain, allowing only small molecules to pass through. Since the population of seniors and patients with CNS problems is growing, global drug development for brain diseases will have to rise substantially in the next 20 years. However, when compared to other therapeutic domains, drug development for brain diseases has the lowest success rates.
Title : Innate Immune memory based therapeutics in the resolution of inflammation
Liwu Li, Virginia Polytechnic Institute and State University, United States
Title : Drugs as an environmental problem chromatographic and computational studies of drugs partition between soil and water
Anna Weronika Sobanska, Medical University of Lodz, Poland
Title : Resveratrol derivatives a new tool for osteogenic induction in the treatment of peri implantitis
Barbara De Filippis, University “G. d’Annunzio, Italy
Title : Comparative Study on Inhibition of Pancreatic Cancer Cells by Resveratrol Gold Nanoparticle and Resveratrol Nanoemulsion Prepared from Grape Skin
Bing Huei Chen, Fu Jen Catholic University, Taiwan
Title : Adiposome a Hydrophobic Drug Delivery System
Pingsheng Liu, Chinese Academy of Sciences, China
Title : Targeting breast cancer through prodrug activation by cytochrome P450 1A1
Sebastien Fortin, Laval University, Canada